Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Natan Ponieman

Magic Mushrooms For Depression: Clinical Trial Of Active Compound Approved For Patients Using Antidepressants

Health Canada has allowed a phase 2 clinical trial of psilocybin in patients currently undergoing treatment with traditional antidepressants.

What Happened: A phase 2 trial on psilocybin, the active compound in “magic mushrooms,” will be led by Cybin Therapeutics, a privately-held psychedelics company (not to be confused with publicly-listed Cybin Inc. (NYSE: CYBN).

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.